Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
|
Total |
Total The Joint Corp. stockholders' equity |
Common Stock |
Additional Paid In Capital |
Treasury Stock |
Accumulated Deficit |
Non-controlling interest |
| Balance, beginning common stock (in shares) at Dec. 31, 2023 |
|
|
14,783,757
|
|
|
|
|
| Balance, beginning at Dec. 31, 2023 |
$ 24,771,882
|
$ 24,746,882
|
$ 14,783
|
$ 47,498,151
|
$ (860,475)
|
$ (21,905,577)
|
$ 25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2023 |
|
|
|
|
32,124
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
493,395
|
493,395
|
|
493,395
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
184,790
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
|
$ 184
|
(184)
|
|
|
|
| Exercise of stock options (in shares) |
|
|
0
|
|
|
|
|
| Exercise of stock options |
0
|
0
|
$ 0
|
0
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
707
|
|
|
| Purchases of treasury stock under employee stock plans |
(6,562)
|
(6,562)
|
|
|
$ (6,562)
|
|
|
| Net income (loss) |
946,979
|
946,979
|
|
|
|
946,979
|
|
| Balance, ending common stock (in shares) at Mar. 31, 2024 |
|
|
14,968,547
|
|
|
|
|
| Balance, ending at Mar. 31, 2024 |
26,205,694
|
26,180,694
|
$ 14,967
|
47,991,362
|
$ (867,037)
|
(20,958,598)
|
25,000
|
| Balance, ending treasury stock (in shares) at Mar. 31, 2024 |
|
|
|
|
32,831
|
|
|
| Balance, beginning common stock (in shares) at Dec. 31, 2023 |
|
|
14,783,757
|
|
|
|
|
| Balance, beginning at Dec. 31, 2023 |
24,771,882
|
24,746,882
|
$ 14,783
|
47,498,151
|
$ (860,475)
|
(21,905,577)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2023 |
|
|
|
|
32,124
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Purchases of treasury stock under employee stock plans |
(9,583)
|
|
|
|
|
|
|
| Net income (loss) |
(5,814,558)
|
|
|
|
|
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2024 |
|
|
14,991,462
|
|
|
|
|
| Balance, ending at Sep. 30, 2024 |
20,475,549
|
20,450,549
|
$ 14,991
|
49,025,751
|
$ (870,058)
|
(27,720,135)
|
25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2024 |
|
|
|
|
33,015
|
|
|
| Balance, beginning common stock (in shares) at Mar. 31, 2024 |
|
|
14,968,547
|
|
|
|
|
| Balance, beginning at Mar. 31, 2024 |
26,205,694
|
26,180,694
|
$ 14,967
|
47,991,362
|
$ (867,037)
|
(20,958,598)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Mar. 31, 2024 |
|
|
|
|
32,831
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
552,065
|
552,065
|
|
552,065
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
21,905
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
|
$ 23
|
(23)
|
|
|
|
| Exercise of stock options (in shares) |
|
|
6,335
|
|
|
|
|
| Exercise of stock options |
52,098
|
52,098
|
$ 6
|
52,092
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
184
|
|
|
| Purchases of treasury stock under employee stock plans |
(3,021)
|
(3,021)
|
|
|
$ (3,021)
|
|
|
| Net income (loss) |
(3,596,398)
|
(3,596,398)
|
|
|
|
(3,596,398)
|
|
| Balance, ending common stock (in shares) at Jun. 30, 2024 |
|
|
14,996,787
|
|
|
|
|
| Balance, ending at Jun. 30, 2024 |
23,210,438
|
23,185,438
|
$ 14,996
|
48,595,496
|
$ (870,058)
|
(24,554,996)
|
25,000
|
| Balance, ending treasury stock (in shares) at Jun. 30, 2024 |
|
|
|
|
33,015
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
430,250
|
430,250
|
|
430,250
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
(5,325)
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
|
$ (5)
|
5
|
|
|
|
| Exercise of stock options (in shares) |
|
|
0
|
|
|
|
|
| Exercise of stock options |
0
|
0
|
$ 0
|
0
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
0
|
|
|
| Purchases of treasury stock under employee stock plans |
0
|
0
|
|
|
$ 0
|
|
|
| Net income (loss) |
(3,165,139)
|
(3,165,139)
|
|
|
|
(3,165,139)
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2024 |
|
|
14,991,462
|
|
|
|
|
| Balance, ending at Sep. 30, 2024 |
$ 20,475,549
|
20,450,549
|
$ 14,991
|
49,025,751
|
$ (870,058)
|
(27,720,135)
|
25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2024 |
|
|
|
|
33,015
|
|
|
| Balance, beginning common stock (in shares) at Dec. 31, 2024 |
15,159,878
|
|
15,192,893
|
|
|
|
|
| Balance, beginning at Dec. 31, 2024 |
$ 20,678,119
|
20,653,119
|
$ 15,192
|
49,210,455
|
$ (870,058)
|
(27,702,470)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2024 |
33,015
|
|
|
|
33,015
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
$ 293,941
|
293,941
|
|
293,941
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
148,565
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
|
$ 149
|
(149)
|
|
|
|
| Exercise of stock options (in shares) |
|
|
3,000
|
|
|
|
|
| Exercise of stock options |
905,976
|
905,976
|
$ 3
|
905,973
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
779
|
|
|
| Purchases of treasury stock under employee stock plans |
(8,440)
|
(8,440)
|
|
|
$ (8,440)
|
|
|
| Net income (loss) |
967,796
|
967,796
|
|
|
|
967,796
|
|
| Balance, ending common stock (in shares) at Mar. 31, 2025 |
|
|
15,344,458
|
|
|
|
|
| Balance, ending at Mar. 31, 2025 |
$ 22,837,392
|
22,812,392
|
$ 15,344
|
50,410,220
|
$ (878,498)
|
(26,734,674)
|
25,000
|
| Balance, ending treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
33,794
|
|
|
| Balance, beginning common stock (in shares) at Dec. 31, 2024 |
15,159,878
|
|
15,192,893
|
|
|
|
|
| Balance, beginning at Dec. 31, 2024 |
$ 20,678,119
|
20,653,119
|
$ 15,192
|
49,210,455
|
$ (870,058)
|
(27,702,470)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Dec. 31, 2024 |
33,015
|
|
|
|
33,015
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Purchases of treasury stock under employee stock plans |
$ (8,440)
|
|
|
|
|
|
|
| Common stock repurchased under authorized repurchase plans |
(2,300,000)
|
|
|
|
|
|
|
| Net income (loss) |
$ 1,916,168
|
|
|
|
|
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2025 |
15,172,257
|
|
15,433,861
|
|
|
|
|
| Balance, ending at Sep. 30, 2025 |
$ 22,721,549
|
22,696,549
|
$ 15,433
|
51,634,910
|
$ (3,167,492)
|
(25,786,302)
|
25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2025 |
261,604
|
|
|
|
261,604
|
|
|
| Balance, beginning common stock (in shares) at Mar. 31, 2025 |
|
|
15,344,458
|
|
|
|
|
| Balance, beginning at Mar. 31, 2025 |
$ 22,837,392
|
22,812,392
|
$ 15,344
|
50,410,220
|
$ (878,498)
|
(26,734,674)
|
25,000
|
| Balance, beginning treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
33,794
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
330,988
|
330,988
|
|
330,988
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
20,064
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
|
$ 20
|
(20)
|
|
|
|
| Exercise of stock options (in shares) |
|
|
0
|
|
|
|
|
| Exercise of stock options |
0
|
0
|
$ 0
|
0
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
0
|
|
|
| Purchases of treasury stock under employee stock plans |
0
|
0
|
|
|
$ 0
|
|
|
| Net income (loss) |
93,363
|
93,363
|
|
|
|
93,363
|
|
| Balance, ending common stock (in shares) at Jun. 30, 2025 |
|
|
15,364,522
|
|
|
|
|
| Balance, ending at Jun. 30, 2025 |
23,261,743
|
23,236,743
|
$ 15,364
|
50,741,188
|
$ (878,498)
|
(26,641,311)
|
25,000
|
| Balance, ending treasury stock (in shares) at Jun. 30, 2025 |
|
|
|
|
33,794
|
|
|
| Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Stock-based compensation expense |
346,209
|
346,209
|
|
346,209
|
|
|
|
| Issuance of restricted stock, net of forfeitures (in shares) |
|
|
(29,376)
|
|
|
|
|
| Issuance of restricted stock, net of forfeitures |
0
|
|
$ (29)
|
29
|
|
|
|
| Exercise of stock options (in shares) |
|
|
98,715
|
|
|
|
|
| Exercise of stock options |
547,582
|
547,582
|
$ 98
|
547,484
|
|
|
|
| Purchases of treasury stock under employee stock plans (in shares) |
|
|
|
|
0
|
|
|
| Purchases of treasury stock under employee stock plans |
$ 0
|
0
|
|
|
$ 0
|
|
|
| Common stock repurchased under authorized repurchase plans (in shares) |
227,810
|
|
|
|
227,810
|
|
|
| Common stock repurchased under authorized repurchase plans |
$ (2,288,994)
|
(2,288,994)
|
|
|
$ (2,288,994)
|
|
|
| Net income (loss) |
$ 855,009
|
855,009
|
|
|
|
855,009
|
|
| Balance, ending common stock (in shares) at Sep. 30, 2025 |
15,172,257
|
|
15,433,861
|
|
|
|
|
| Balance, ending at Sep. 30, 2025 |
$ 22,721,549
|
$ 22,696,549
|
$ 15,433
|
$ 51,634,910
|
$ (3,167,492)
|
$ (25,786,302)
|
$ 25,000
|
| Balance, ending treasury stock (in shares) at Sep. 30, 2025 |
261,604
|
|
|
|
261,604
|
|
|